Measurement properties of the Haem-A-QoL in haemophilia clinical trials.

about

Measurement properties of the Haem-A-QoL in haemophilia clinical trials.

Item

http://www.wikidata.org/entity/Q39062772

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Measurement properties of the Haem-A-QoL in haemophilia clinical trials.

@en

Measurement properties of the Haem-A-QoL in haemophilia clinical trials.

@nl

type

Item

label

Measurement properties of the Haem-A-QoL in haemophilia clinical trials.

@en

Measurement properties of the Haem-A-QoL in haemophilia clinical trials.

@nl

prefLabel

Measurement properties of the Haem-A-QoL in haemophilia clinical trials.

@en

Measurement properties of the Haem-A-QoL in haemophilia clinical trials.

@nl

P1476

Measurement properties of the Haem-A-QoL in haemophilia clinical trials.

@en

P2093

A Eldar-Lissai

http://www.w3.org/2001/XMLSchema#string

K W Wyrwich

http://www.w3.org/2001/XMLSchema#string

P Auguste

http://www.w3.org/2001/XMLSchema#string

R Yu

http://www.w3.org/2001/XMLSchema#string

R von Maltzahn

http://www.w3.org/2001/XMLSchema#string

S Krishnan

http://www.w3.org/2001/XMLSchema#string

S von Mackensen

http://www.w3.org/2001/XMLSchema#string

P2860

EuroQol--a new facility for the measurement of health-related quality of life

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.

Quality of life and sports activities in patients with haemophilia.

Extending half-life in coagulation factors: where do we stand?

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.

Future characteristics of bypassing agents to improve care of hemophilia inhibitor patients: an economic and health-related quality of life perspective.

Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: validity of the hemophilia joint health score.

Long-standing prophylactic therapy vs. episodic treatment in young people with severe haemophilia: a comparison of age-matched Danish and Russian patients.

Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B.

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study).

P304

383-391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HAE.13140

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28026074

http://www.w3.org/2001/XMLSchema#string